← Back to Patent Explorer
EP0284261A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Acetylenes disubstituted with a heteroaromatic group and a tetralin group having retinoid like activity

Assignee: Allergan Inc
•
Filing: 1988-03-11
•
Granted: —
•
Expires: 2008-03-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Retinoid-like activity is exhibited by compounds of the formula where R is hydrogen or lower alkyl; A is pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-5; and B is H, -COOH or an ester or amide thereof, -CH₂OH or an ester or ester derivative thereof, or -CHO or an acetal derivative thereof, or -COR₁ or a ketal derivative thereof where R₁ is -(CH₂) m CH₃ where m is 0-4; or a pharmaceutically acceptable salt thereof.

Inventors

  • 👤 Roshantha A.S. Chandraratna

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-03 18:38
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/06; C07D213/60; C07D213/78; C07D213/79; C07D213/80; A; A61; A61P; A61P17/00; A61P27/00; A61P27/02; A61P27/14; A61P29/00; A61P37/00; A61P37/08

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 96 words
A process for making a compound of the formula where R is hydrogen or lower alkyl; A is pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-5; and B is H, a protected acid, alcohol, aldehyde or ketone; which process comprises reacting a compound of formula II with a compound of formula III in the presence of Pd(PQ₃)₄ (Q is phenyl) or a similar complex where X is halogen, preferably I; n and A are defined above; and B is H, a protected acid, alcohol, aldehyde or ketone, giving the corresponding compound of formula I.
Claim 2
Dependent Claim 96 words
A process for making a compound of the formula where R is hydrogen or lower alkyl; A is pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-5; and B is H, a protected acid, alcohol, aldehyde or ketone; which process comprises reacting a compound of formula II with a compound of formula III in the presence of Pd(PQ₃)₄ (Q is phenyl) or a similar complex where X is halogen, preferably I; n and A are defined above; and B is H, a protected acid, alcohol, aldehyde or ketone, giving the corresponding compound of formula I.
Claim 3
Dependent Claim 21 words
The process of claim 1 wherein R is hydrogen or methyl, n is 0, 1 or 2 and A is pyridyl.
Claim 4
Dependent Claim 11 words
The process of claim 2 wherein B is a protected acid.
Claim 5
Dependent Claim 15 words
The process of claim 3 wherein the resulting compound is ethyl 6-[2-(5,5,8,8-tetramethyl-­5,6,7,8-tetrahydronaphth-2-yl)ethynyl]nicotinoate or ethyl 6-[2-(3,5,5,8,8-pentamethyl-5,6,7,8-­tetrahydronaphth-2-yl)ethynyl]nicotinoate.
Claim 6
Dependent Claim 16 words
A process according to claim 1 where A is thienyl and B is a protected acid.
Claim 7
Dependent Claim 16 words
A process according to claim 1 where A is furyl and B is a protected acid.
Claim 8
Dependent Claim 19 words
A process according to claim 1 where A is pyridazinyl, pyrimidinyl or pyrazinyl and B is a protected acid.
Claim 9
Dependent Claim 53 words
A process for making a compound of the formula where R is hydrogen or lower alkyl; A is pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-5; and B is -COOH or a pharmaceutically acceptable salt, an alcohol, aldehyde or ketone which process comprises deprotecting a protected acid, alcohol, aldehyde or ketone.
Claim 10
Dependent Claim 53 words
A process for making a compound of the formula where R is hydrogen or lower alkyl; A is pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-5; and B is -COOH or a pharmaceutically acceptable salt, an alcohol, aldehyde or ketone which process comprises deprotecting a protected acid, alcohol, aldehyde or ketone.
Claim 11
Dependent Claim 17 words
A process of claim 8 which gives 6-[2-­(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphth-2-yl)­ethynyl]nicotinic acid, 6-[2-(3,5,5,8,8-­pentamethyl-5,6,7,8-tetrahydronaphth-2-yl)­ethynyl]nicotinic acid or a pharmaceutically acceptable salt thereof.
Claim 12
Dependent Claim 36 words
A process for preparing a pharmaceutical composition containing a compound of formula I as defined in any one of claims 1 to 10 which process comprises bringing the compound into association with a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

GB2130580A Cited
EP0176034B1 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag